INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹19 Cr | ₹11 Cr | ₹9.39 Cr | ₹6.93 Cr | ₹5.51 Cr |
What is the latest Operating Profit of INDO US BIOTECH ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹9.39 Cr |
| Mar2022 | ₹6.93 Cr |
| Mar2021 | ₹5.51 Cr |
How is Operating Profit of INDO US BIOTECH Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 75.26 | |
| Mar2024 | ₹11 Cr | 15.03 | |
| Mar2023 | ₹9.39 Cr | 35.52 | |
| Mar2022 | ₹6.93 Cr | 25.70 | |
| Mar2021 | ₹5.51 Cr | - | |
Compare Operating Profit of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹302.3 Cr | 13% | 30.2% | -32.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,384.5 Cr | -1.4% | 0.1% | -4.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,178.7 Cr | -4% | -2.8% | -10.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,938.8 Cr | -3% | -7.9% | -16.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹967.1 Cr | 0.2% | -3.1% | -34.6% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹383.9 Cr | -4.1% | -8.5% | -4.9% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 13% |
30.2% |
-32.5% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses